Suchergebnis | Hamburg Open Science

Facetten

17 Einträge gefunden

A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
2008 - Forschungsinformationssystem des UKE
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
2008 - Forschungsinformationssystem des UKE
Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.
2008 - Forschungsinformationssystem des UKE
Development and external validation of an extended 10-core biopsy nomogram.
2007 - Forschungsinformationssystem des UKE
Prostate volume and adverse prostate cancer features: fact not artifact.
2007 - Forschungsinformationssystem des UKE
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
2007 - Forschungsinformationssystem des UKE
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
2007 - Forschungsinformationssystem des UKE
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
2007 - Forschungsinformationssystem des UKE
Ejaculatory disorders may affect screening for prostate cancer.
2007 - Forschungsinformationssystem des UKE
External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
2007 - Forschungsinformationssystem des UKE
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
2007 - Forschungsinformationssystem des UKE
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
2007 - Forschungsinformationssystem des UKE
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.

Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.

Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.

Development and external validation of an extended 10-core biopsy nomogram.

Prostate volume and adverse prostate cancer features: fact not artifact.

Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.

Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.

Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.

A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.

Ejaculatory disorders may affect screening for prostate cancer.

External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy.

Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.

Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.

Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.